Centene Corp
CNC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$12.00 | Sqdnj | Zvfzfmwm |
Centene Earnings: Individual Plan Growth Offsets Medicaid Redetermination Effects
Narrow-moat Centene exceeded expectations in the second quarter on strength in its relatively high-margin individual plans, and the company maintained its guidance for the full year. We are keeping our $92 fair value estimate intact and continue to view Centene shares as moderately undervalued.